Drugs / Bio-three
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01480947 | Feb 2009 → Dec 2010 | diarrheal disease, gastroenteritis | Kaohsiung Veterans General Hospital. | Completed | No outcome recorded |
| Phase 4 | NCT00463190 | Feb 2006 → Nov 2007 | diarrheal disease, enteritis, enterocolitis | Chang Gung Memorial Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bio-three | “The effect of Bio-Three (Enterococcus T-110, C. butyricum TO-A, B. mesentericus TO-A) was ever proved on (a) normalization of enterobacterial flora, (b) improvement of growing...” NCT00463190 ↗3“Children (n = 304) aged 3 months to 6 years hospitalized for acute diarrhea were randomized to receive Bio-three (a mixture of Bacillus mesentericus, Enterococcus faecalis, and...” PMID 20135748 ↗ Feb 2010 “add-on treatment of the probiotics (Bio-three®) to the control treatment” NCT01480947 ↗ |
| Modality | Other / unclassified | “a probiotic which contains three independent probiotics” NCT01480947 ↗ |
| Route | Oral | “receive Bio-three (a mixture of Bacillus mesentericus, Enterococcus faecalis, and Clostridium butyricum) or placebo orally 3 times daily for 7 days.” PMID 20135748 ↗ Feb 2010 |